ID   TTLL5_HUMAN             Reviewed;        1281 AA.
AC   Q6EMB2; B9EGH8; B9EGH9; Q9BUB0; Q9H0G4; Q9H7W2; Q9P1V5; Q9UPZ4;
DT   21-FEB-2006, integrated into UniProtKB/Swiss-Prot.
DT   16-JUN-2009, sequence version 3.
DT   28-JUN-2023, entry version 144.
DE   RecName: Full=Tubulin polyglutamylase TTLL5 {ECO:0000250|UniProtKB:Q8CHB8};
DE            EC=6.3.2.- {ECO:0000250|UniProtKB:Q8CHB8};
DE   AltName: Full=SRC1 and TIF2-associated modulatory protein {ECO:0000303|PubMed:17116691};
DE            Short=STAMP protein {ECO:0000303|PubMed:17116691};
DE   AltName: Full=Tubulin--tyrosine ligase-like protein 5;
GN   Name=TTLL5 {ECO:0000312|HGNC:HGNC:19963};
GN   Synonyms=KIAA0998, STAMP {ECO:0000303|PubMed:17116691};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION,
RP   INTERACTION WITH NCOA1 AND NCOA2, TISSUE SPECIFICITY, AND VARIANTS VAL-149
RP   AND SER-1267.
RC   TISSUE=Testis;
RX   PubMed=17116691; DOI=10.1128/mcb.01360-06;
RA   He Y., Simons S.S. Jr.;
RT   "STAMP, a novel predicted factor assisting TIF2 actions in glucocorticoid
RT   receptor-mediated induction and repression.";
RL   Mol. Cell. Biol. 27:1467-1485(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT VAL-149.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANT
RP   VAL-149.
RC   TISSUE=Brain, Testis, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 24-1281 (ISOFORM 3).
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 56-1281 (ISOFORM 1), AND VARIANTS
RP   VAL-149 AND SER-1267.
RC   TISSUE=Brain;
RX   PubMed=10231032; DOI=10.1093/dnares/6.1.63;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 6:63-70(1999).
RN   [9]
RP   FUNCTION.
RX   PubMed=22493317; DOI=10.1091/mbc.e11-11-0931;
RA   Backer C.B., Gutzman J.H., Pearson C.G., Cheeseman I.M.;
RT   "CSAP localizes to polyglutamylated microtubules and promotes proper cilia
RT   function and zebrafish development.";
RL   Mol. Biol. Cell 23:2122-2130(2012).
RN   [10]
RP   INVOLVEMENT IN CORD19, VARIANT CORD19 LYS-543, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=24791901; DOI=10.1016/j.ajhg.2014.04.003;
RG   UCL-Exomes Consortium;
RA   Sergouniotis P.I., Chakarova C., Murphy C., Becker M., Lenassi E., Arno G.,
RA   Lek M., MacArthur D.G., Bhattacharya S.S., Moore A.T., Holder G.E.,
RA   Robson A.G., Wolfrum U., Webster A.R., Plagnol V.;
RT   "Biallelic variants in TTLL5, encoding a tubulin glutamylase, cause retinal
RT   dystrophy.";
RL   Am. J. Hum. Genet. 94:760-769(2014).
RN   [11]
RP   DOMAIN, AND MUTAGENESIS OF 467-LYS--LYS-473.
RX   PubMed=25959773; DOI=10.1016/j.cell.2015.04.003;
RA   Garnham C.P., Vemu A., Wilson-Kubalek E.M., Yu I., Szyk A., Lander G.C.,
RA   Milligan R.A., Roll-Mecak A.;
RT   "Multivalent microtubule recognition by tubulin tyrosine ligase-like family
RT   glutamylases.";
RL   Cell 161:1112-1123(2015).
CC   -!- FUNCTION: Polyglutamylase which modifies tubulin, generating
CC       polyglutamate side chains on the gamma-carboxyl group of specific
CC       glutamate residues within the C-terminal tail of tubulin.
CC       Preferentially mediates ATP-dependent initiation step of the
CC       polyglutamylation reaction over the elongation step. Preferentially
CC       modifies the alpha-tubulin tail over a beta-tail (By similarity).
CC       Required for CCSAP localization to both polyglutamylated spindle and
CC       cilia microtubules (PubMed:22493317). Increases the effects of
CC       transcriptional coactivator NCOA2/TIF2 in glucocorticoid receptor-
CC       mediated repression and induction and in androgen receptor-mediated
CC       induction (PubMed:17116691). {ECO:0000250|UniProtKB:Q8CHB8,
CC       ECO:0000269|PubMed:17116691, ECO:0000269|PubMed:22493317}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-glutamate + L-glutamyl-[protein] = ADP + gamma-L-
CC         glutamyl-L-glutamyl-[protein] + H(+) + phosphate;
CC         Xref=Rhea:RHEA:60144, Rhea:RHEA-COMP:10208, Rhea:RHEA-COMP:15517,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29973, ChEBI:CHEBI:29985,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:143622,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:Q8CHB8};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60145;
CC         Evidence={ECO:0000250|UniProtKB:Q8CHB8};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(L-glutamyl)(n)-gamma-L-glutamyl-L-glutamyl-[protein] + ATP +
CC         L-glutamate = (L-glutamyl)(n+1)-gamma-L-glutamyl-L-glutamyl-[protein]
CC         + ADP + H(+) + phosphate; Xref=Rhea:RHEA:60148, Rhea:RHEA-COMP:15519,
CC         Rhea:RHEA-COMP:15675, ChEBI:CHEBI:15378, ChEBI:CHEBI:29985,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:143623,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:Q8CHB8};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60149;
CC         Evidence={ECO:0000250|UniProtKB:Q8CHB8};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:A4Q9E8};
CC   -!- SUBUNIT: Interacts with the transcriptional coactivators NCOA1/SRC-1
CC       and NCOA2/TIF2. {ECO:0000269|PubMed:17116691}.
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium
CC       {ECO:0000269|PubMed:24791901}. Cytoplasm, cytoskeleton, cilium basal
CC       body {ECO:0000250|UniProtKB:Q8CHB8}. Nucleus
CC       {ECO:0000269|PubMed:17116691}. Cytoplasm {ECO:0000269|PubMed:17116691}.
CC       Note=Localized to the base of the connecting cilium between the basal
CC       body and the adjacent daughter centriole of the cilium. In osteosarcoma
CC       cells, found in both cytoplasm and nucleus in the absence of steroid
CC       but located exclusively in the nucleus in the presence of steroid.
CC       {ECO:0000250|UniProtKB:Q8CHB8, ECO:0000269|PubMed:24791901}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q6EMB2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6EMB2-2; Sequence=VSP_037453, VSP_037456, VSP_037457;
CC       Name=3;
CC         IsoId=Q6EMB2-3; Sequence=VSP_037454, VSP_037455;
CC   -!- TISSUE SPECIFICITY: Expressed in the retina, found in the rod and cone
CC       photoreceptors (at protein level). Widely expressed with highest levels
CC       in heart and skeletal muscle and low levels in other tissues.
CC       {ECO:0000269|PubMed:17116691, ECO:0000269|PubMed:24791901}.
CC   -!- DOMAIN: The flexible c-MTBD (cationic microtubule binding domain)
CC       region mediates binding to microtubules. It is positively charged and
CC       becomes ordered when bound to microtubules: it interacts with a
CC       negatively charged patch on tubulin. The presence of positive charges
CC       in the c-MTBD region is essential for proper binding.
CC       {ECO:0000250|UniProtKB:Q6ZT98, ECO:0000269|PubMed:25959773}.
CC   -!- DOMAIN: Arg-186 is the main determinant for regioselectivity, which
CC       segregates between initiases and elongases in all tubulin--tyrosine
CC       ligase family. A glutamine residue at this position is found in
CC       elongases TTLL6, TTLL9, TTLL11, TTLL13, TTLL10 and favors glutamate-
CC       chain elongation, whereas an arginine residue is found in initiases
CC       TTLL2, TTLL4, TTLL5, TTLL3, TTLL8 and favors initiation.
CC       {ECO:0000250|UniProtKB:A4Q9E8}.
CC   -!- DISEASE: Cone-rod dystrophy 19 (CORD19) [MIM:615860]: A form of cone-
CC       rod dystrophy, an inherited retinal dystrophy characterized by retinal
CC       pigment deposits visible on fundus examination, predominantly in the
CC       macular region, and initial loss of cone photoreceptors followed by rod
CC       degeneration. This leads to decreased visual acuity and sensitivity in
CC       the central visual field, followed by loss of peripheral vision. Severe
CC       loss of vision occurs earlier than in retinitis pigmentosa, due to cone
CC       photoreceptors degenerating at a higher rate than rod photoreceptors.
CC       {ECO:0000269|PubMed:24791901}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the tubulin--tyrosine ligase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF23275.2; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=AAP75557.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY237126; AAP75557.1; ALT_INIT; mRNA.
DR   EMBL; AC007182; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC009399; AAF23275.2; ALT_SEQ; Genomic_DNA.
DR   EMBL; AF107885; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471061; EAW81247.1; -; Genomic_DNA.
DR   EMBL; CR533554; CAG38585.1; -; mRNA.
DR   EMBL; AL136808; CAB66742.1; -; mRNA.
DR   EMBL; BC002766; AAH02766.2; -; mRNA.
DR   EMBL; BC136472; AAI36473.1; -; mRNA.
DR   EMBL; BC136473; AAI36474.1; -; mRNA.
DR   EMBL; AK024259; BAB14862.1; -; mRNA.
DR   EMBL; AB023215; BAA76842.1; -; mRNA.
DR   CCDS; CCDS32124.1; -. [Q6EMB2-1]
DR   RefSeq; NP_055887.3; NM_015072.4. [Q6EMB2-1]
DR   AlphaFoldDB; Q6EMB2; -.
DR   SMR; Q6EMB2; -.
DR   BioGRID; 116721; 53.
DR   IntAct; Q6EMB2; 25.
DR   MINT; Q6EMB2; -.
DR   STRING; 9606.ENSP00000298832; -.
DR   GlyCosmos; Q6EMB2; 1 site, 1 glycan.
DR   GlyGen; Q6EMB2; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q6EMB2; -.
DR   PhosphoSitePlus; Q6EMB2; -.
DR   BioMuta; TTLL5; -.
DR   DMDM; 239938834; -.
DR   EPD; Q6EMB2; -.
DR   jPOST; Q6EMB2; -.
DR   MassIVE; Q6EMB2; -.
DR   MaxQB; Q6EMB2; -.
DR   PaxDb; Q6EMB2; -.
DR   PeptideAtlas; Q6EMB2; -.
DR   ProteomicsDB; 66285; -. [Q6EMB2-1]
DR   ProteomicsDB; 66286; -. [Q6EMB2-2]
DR   ProteomicsDB; 66287; -. [Q6EMB2-3]
DR   Antibodypedia; 25856; 65 antibodies from 13 providers.
DR   DNASU; 23093; -.
DR   Ensembl; ENST00000286650.9; ENSP00000286650.5; ENSG00000119685.20. [Q6EMB2-3]
DR   Ensembl; ENST00000298832.14; ENSP00000298832.9; ENSG00000119685.20. [Q6EMB2-1]
DR   Ensembl; ENST00000556893.5; ENSP00000452524.1; ENSG00000119685.20. [Q6EMB2-2]
DR   GeneID; 23093; -.
DR   KEGG; hsa:23093; -.
DR   MANE-Select; ENST00000298832.14; ENSP00000298832.9; NM_015072.5; NP_055887.3.
DR   UCSC; uc001xrw.3; human. [Q6EMB2-1]
DR   AGR; HGNC:19963; -.
DR   CTD; 23093; -.
DR   DisGeNET; 23093; -.
DR   GeneCards; TTLL5; -.
DR   HGNC; HGNC:19963; TTLL5.
DR   HPA; ENSG00000119685; Tissue enhanced (testis).
DR   MalaCards; TTLL5; -.
DR   MIM; 612268; gene.
DR   MIM; 615860; phenotype.
DR   neXtProt; NX_Q6EMB2; -.
DR   OpenTargets; ENSG00000119685; -.
DR   Orphanet; 1872; Cone rod dystrophy.
DR   PharmGKB; PA164742694; -.
DR   VEuPathDB; HostDB:ENSG00000119685; -.
DR   eggNOG; KOG2156; Eukaryota.
DR   eggNOG; KOG2157; Eukaryota.
DR   GeneTree; ENSGT00940000162939; -.
DR   HOGENOM; CLU_1034260_0_0_1; -.
DR   InParanoid; Q6EMB2; -.
DR   OrthoDB; 7265at2759; -.
DR   PhylomeDB; Q6EMB2; -.
DR   TreeFam; TF313087; -.
DR   PathwayCommons; Q6EMB2; -.
DR   Reactome; R-HSA-8955332; Carboxyterminal post-translational modifications of tubulin.
DR   SignaLink; Q6EMB2; -.
DR   BioGRID-ORCS; 23093; 16 hits in 1159 CRISPR screens.
DR   ChiTaRS; TTLL5; human.
DR   GenomeRNAi; 23093; -.
DR   Pharos; Q6EMB2; Tbio.
DR   PRO; PR:Q6EMB2; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q6EMB2; protein.
DR   Bgee; ENSG00000119685; Expressed in left testis and 205 other tissues.
DR   ExpressionAtlas; Q6EMB2; baseline and differential.
DR   Genevisible; Q6EMB2; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005929; C:cilium; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0015631; F:tubulin binding; IBA:GO_Central.
DR   GO; GO:0070740; F:tubulin-glutamic acid ligase activity; ISS:UniProtKB.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0018095; P:protein polyglutamylation; IBA:GO_Central.
DR   GO; GO:0060041; P:retina development in camera-type eye; IMP:MGI.
DR   Gene3D; 3.30.470.20; ATP-grasp fold, B domain; 1.
DR   InterPro; IPR004344; TTL/TTLL_fam.
DR   PANTHER; PTHR12241; TUBULIN POLYGLUTAMYLASE; 1.
DR   PANTHER; PTHR12241:SF145; TUBULIN POLYGLUTAMYLASE TTLL5; 1.
DR   Pfam; PF03133; TTL; 1.
DR   SUPFAM; SSF56059; Glutathione synthetase ATP-binding domain-like; 1.
DR   PROSITE; PS51221; TTL; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell projection; Cilium;
KW   Cone-rod dystrophy; Cytoplasm; Cytoskeleton; Disease variant; Ligase;
KW   Magnesium; Metal-binding; Microtubule; Nucleotide-binding; Nucleus;
KW   Reference proteome; Transcription.
FT   CHAIN           1..1281
FT                   /note="Tubulin polyglutamylase TTLL5"
FT                   /id="PRO_0000223341"
FT   DOMAIN          62..407
FT                   /note="TTL"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00568"
FT   REGION          378..488
FT                   /note="c-MTBD region"
FT                   /evidence="ECO:0000269|PubMed:25959773"
FT   REGION          577..614
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1072..1114
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1199..1281
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        582..604
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1072..1112
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1236..1281
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         180
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:A4Q9E8"
FT   BINDING         186..187
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:A4Q9E8"
FT   BINDING         186
FT                   /ligand="a protein"
FT                   /ligand_id="ChEBI:CHEBI:16541"
FT                   /ligand_part="L-glutamate residue"
FT                   /ligand_part_id="ChEBI:CHEBI:29973"
FT                   /ligand_part_note="L-glutamate acceptor residue in protein
FT                   target"
FT                   /evidence="ECO:0000250|UniProtKB:A4Q9E8"
FT   BINDING         208..211
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:A4Q9E8"
FT   BINDING         221..223
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:A4Q9E8"
FT   BINDING         247
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:A4Q9E8"
FT   BINDING         268..269
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:A4Q9E8"
FT   BINDING         270
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:A4Q9E8"
FT   BINDING         271
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:A4Q9E8"
FT   BINDING         293
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:A4Q9E8"
FT   BINDING         353
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:A4Q9E8"
FT   BINDING         366
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:A4Q9E8"
FT   BINDING         366
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:A4Q9E8"
FT   BINDING         368
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:A4Q9E8"
FT   BINDING         384
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:A4Q9E8"
FT   SITE            186
FT                   /note="Essential for specifying initiation versus
FT                   elongation step of the polyglutamylase activity"
FT                   /evidence="ECO:0000250|UniProtKB:A4Q9E8"
FT   VAR_SEQ         1..462
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11230166, ECO:0000303|Ref.5"
FT                   /id="VSP_037453"
FT   VAR_SEQ         248..269
FT                   /note="FATVRYDQGAKNIRNQFMHLTN -> KCNWKMGNTMDKRRLPIYVQVL (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_037454"
FT   VAR_SEQ         270..1281
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_037455"
FT   VAR_SEQ         516
FT                   /note="D -> DRGNPRRSLLTGRT (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11230166, ECO:0000303|Ref.5"
FT                   /id="VSP_037456"
FT   VAR_SEQ         1247..1281
FT                   /note="KGSSAEGQLNGLQSSLNPAAFVPITSSTDPAHTKI -> NTRFRSSFQNYLW
FT                   YFFQAVS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11230166, ECO:0000303|Ref.5"
FT                   /id="VSP_037457"
FT   VARIANT         149
FT                   /note="A -> V (in dbSNP:rs2303345)"
FT                   /evidence="ECO:0000269|PubMed:10231032,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17116691,
FT                   ECO:0000269|Ref.3"
FT                   /id="VAR_057895"
FT   VARIANT         203
FT                   /note="E -> D (in dbSNP:rs17856074)"
FT                   /id="VAR_057896"
FT   VARIANT         543
FT                   /note="E -> K (in CORD19; dbSNP:rs199882533)"
FT                   /evidence="ECO:0000269|PubMed:24791901"
FT                   /id="VAR_071327"
FT   VARIANT         592
FT                   /note="A -> T (in dbSNP:rs11848004)"
FT                   /id="VAR_057897"
FT   VARIANT         1223
FT                   /note="A -> S (in dbSNP:rs10130991)"
FT                   /id="VAR_057898"
FT   VARIANT         1231
FT                   /note="P -> T (in dbSNP:rs11844617)"
FT                   /id="VAR_057899"
FT   VARIANT         1267
FT                   /note="F -> S (in dbSNP:rs1133834)"
FT                   /evidence="ECO:0000269|PubMed:10231032,
FT                   ECO:0000269|PubMed:17116691"
FT                   /id="VAR_057900"
FT   MUTAGEN         467..473
FT                   /note="KVLRRVK->DVLDDVD: Decreased binding to microtubules
FT                   and polyglutamylase activity."
FT                   /evidence="ECO:0000269|PubMed:25959773"
SQ   SEQUENCE   1281 AA;  143577 MW;  01441AFE6925AEDF CRC64;
     MPIVMARDLE ETASSSEDEE VISQEDHPCI MWTGGCRRIP VLVFHADAIL TKDNNIRVIG
     ERYHLSYKIV RTDSRLVRSI LTAHGFHEVH PSSTDYNLMW TGSHLKPFLL RTLSEAQKVN
     HFPRSYELTR KDRLYKNIIR MQHTHGFKAF HILPQTFLLP AEYAEFCNSY SKDRGPWIVK
     PVASSRGRGV YLINNPNQIS LEENILVSRY INNPLLIDDF KFDVRLYVLV TSYDPLVIYL
     YEEGLARFAT VRYDQGAKNI RNQFMHLTNY SVNKKSGDYV SCDDPEVEDY GNKWSMSAML
     RYLKQEGRDT TALMAHVEDL IIKTIISAEL AIATACKTFV PHRSSCFELY GFDVLIDSTL
     KPWLLEVNLS PSLACDAPLD LKIKASMISD MFTVVGFVCQ DPAQRASTRP IYPTFESSRR
     NPFQKPQRCR PLSASDAEMK NLVGSAREKG PGKLGGSVLG LSMEEIKVLR RVKEENDRRG
     GFIRIFPTSE TWEIYGSYLE HKTSMNYMLA TRLFQDRMTA DGAPELKIES LNSKAKLHAA
     LYERKLLSLE VRKRRRRSSR LRAMRPKYPV ITQPAEMNVK TETESEEEEE VALDNEDEEQ
     EASQEESAGF LRENQAKYTP SLTALVENTP KENSMKVREW NNKGGHCCKL ETQELEPKFN
     LMQILQDNGN LSKMQARIAF SAYLQHVQIR LMKDSGGQTF SASWAAKEDE QMELVVRFLK
     RASNNLQHSL RMVLPSRRLA LLERRRILAH QLGDFIIVYN KETEQMAEKK SKKKVEEEEE
     DGVNMENFQE FIRQASEAEL EEVLTFYTQK NKSASVFLGT HSKISKNNNN YSDSGAKGDH
     PETIMEEVKI KPPKQQQTTE IHSDKLSRFT TSAEKEAKLV YSNSSSGPTA TLQKIPNTHL
     SSVTTSDLSP GPCHHSSLSQ IPSAIPSMPH QPTILLNTVS ASASPCLHPG AQNIPSPTGL
     PRCRSGSHTI GPFSSFQSAA HIYSQKLSRP SSAKAGSCYL NKHHSGIAKT QKEGEDASLY
     SKRYNQSMVT AELQRLAEKQ AARQYSPSSH INLLTQQVTN LNLATGIINR SSASAPPTLR
     PIISPSGPTW STQSDPQAPE NHSSSPGSRS LQTGGFAWEG EVENNVYSQA TGVVPQHKYH
     PTAGSYQLQF ALQQLEQQKL QSRQLLDQSR ARHQAIFGSQ TLPNSNLWTM NNGAGCRISS
     ATASGQKPTT LPQKVVPPPS SCASLVPKPP PNHEQVLRRA TSQKASKGSS AEGQLNGLQS
     SLNPAAFVPI TSSTDPAHTK I
//
